vs
Aurinia Pharmaceuticals Inc.（AUPH）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
Resolute Holdings Management, Inc.的季度营收约是Aurinia Pharmaceuticals Inc.的1.5倍（$117.7M vs $77.1M），Aurinia Pharmaceuticals Inc.净利率更高（273.4% vs -1.5%，领先274.8%）
Aurinia Pharmaceuticals是一家生物制药企业，专注于自身免疫疾病及肾脏疾病靶向疗法的研发与商业化，核心获批产品为用于治疗成人活动性狼疮性肾炎的Lupkynis，主要市场覆盖北美及欧洲地区。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
AUPH vs RHLD — 直观对比
营收规模更大
RHLD
是对方的1.5倍
$77.1M
净利率更高
AUPH
高出274.8%
-1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $77.1M | $117.7M |
| 净利润 | $210.8M | $-1.7M |
| 毛利率 | 88.6% | 55.7% |
| 营业利润率 | 43.1% | 30.2% |
| 净利率 | 273.4% | -1.5% |
| 营收同比 | 28.8% | — |
| 净利润同比 | 14651.2% | — |
| 每股收益（稀释后） | $1.52 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AUPHRHLD
| Q4 25 | $77.1M | $117.7M | ||
| Q3 25 | $73.5M | $120.9M | ||
| Q2 25 | $70.0M | $119.6M | ||
| Q1 25 | $62.5M | $103.9M | ||
| Q4 24 | $59.9M | — | ||
| Q3 24 | $67.8M | — | ||
| Q2 24 | $57.2M | — | ||
| Q1 24 | $50.3M | — |
净利润AUPHRHLD
| Q4 25 | $210.8M | $-1.7M | ||
| Q3 25 | $31.6M | $-231.0K | ||
| Q2 25 | $21.5M | $-611.0K | ||
| Q1 25 | $23.3M | $-3.4M | ||
| Q4 24 | $1.4M | — | ||
| Q3 24 | $14.3M | — | ||
| Q2 24 | $722.0K | — | ||
| Q1 24 | $-10.7M | — |
毛利率AUPHRHLD
| Q4 25 | 88.6% | 55.7% | ||
| Q3 25 | 88.9% | 59.0% | ||
| Q2 25 | 89.8% | 57.5% | ||
| Q1 25 | 86.3% | 52.5% | ||
| Q4 24 | 90.7% | — | ||
| Q3 24 | 91.1% | — | ||
| Q2 24 | 84.4% | — | ||
| Q1 24 | 84.6% | — |
营业利润率AUPHRHLD
| Q4 25 | 43.1% | 30.2% | ||
| Q3 25 | 40.5% | 34.3% | ||
| Q2 25 | 28.7% | 34.0% | ||
| Q1 25 | 35.0% | 24.7% | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | 17.3% | — | ||
| Q2 24 | -2.6% | — | ||
| Q1 24 | -26.3% | — |
净利率AUPHRHLD
| Q4 25 | 273.4% | -1.5% | ||
| Q3 25 | 42.9% | -0.2% | ||
| Q2 25 | 30.7% | -0.5% | ||
| Q1 25 | 37.4% | -3.2% | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 21.2% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | -21.4% | — |
每股收益（稀释后）AUPHRHLD
| Q4 25 | $1.52 | $-0.20 | ||
| Q3 25 | $0.23 | $-0.03 | ||
| Q2 25 | $0.16 | $-0.07 | ||
| Q1 25 | $0.16 | $-0.39 | ||
| Q4 24 | $0.00 | — | ||
| Q3 24 | $0.10 | — | ||
| Q2 24 | $0.01 | — | ||
| Q1 24 | $-0.07 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.2M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $581.3M | $6.5M |
| 总资产 | $751.6M | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资AUPHRHLD
| Q4 25 | $80.2M | $205.5M | ||
| Q3 25 | $72.9M | $148.0M | ||
| Q2 25 | $52.9M | $99.9M | ||
| Q1 25 | $66.1M | $71.0M | ||
| Q4 24 | $83.4M | — | ||
| Q3 24 | $36.6M | — | ||
| Q2 24 | $33.3M | — | ||
| Q1 24 | $63.9M | — |
总债务AUPHRHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AUPHRHLD
| Q4 25 | $581.3M | $6.5M | ||
| Q3 25 | $365.8M | $10.8M | ||
| Q2 25 | $335.3M | $9.6M | ||
| Q1 25 | $350.2M | $8.9M | ||
| Q4 24 | $377.5M | — | ||
| Q3 24 | $388.0M | — | ||
| Q2 24 | $364.6M | — | ||
| Q1 24 | $359.5M | — |
总资产AUPHRHLD
| Q4 25 | $751.6M | $333.4M | ||
| Q3 25 | $527.5M | $293.2M | ||
| Q2 25 | $502.6M | $253.3M | ||
| Q1 25 | $504.9M | $214.3M | ||
| Q4 24 | $550.6M | — | ||
| Q3 24 | $549.4M | — | ||
| Q2 24 | $523.5M | — | ||
| Q1 24 | $516.6M | — |
负债/权益比AUPHRHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.7M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | — | $189.2M |
| 自由现金流率自由现金流/营收 | — | 160.8% |
| 资本支出强度资本支出/营收 | — | 5.8% |
| 现金转化率经营现金流/净利润 | 0.22× | — |
| 过去12个月自由现金流最近4个季度 | — | $313.2M |
8季度趋势，按日历期对齐
经营现金流AUPHRHLD
| Q4 25 | $45.7M | $196.1M | ||
| Q3 25 | $44.4M | $59.6M | ||
| Q2 25 | $44.2M | $48.9M | ||
| Q1 25 | $1.3M | $18.4M | ||
| Q4 24 | $30.1M | — | ||
| Q3 24 | $17.0M | — | ||
| Q2 24 | $15.8M | — | ||
| Q1 24 | $-18.6M | — |
自由现金流AUPHRHLD
| Q4 25 | — | $189.2M | ||
| Q3 25 | — | $58.6M | ||
| Q2 25 | — | $47.5M | ||
| Q1 25 | — | $17.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率AUPHRHLD
| Q4 25 | — | 160.8% | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 17.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度AUPHRHLD
| Q4 25 | — | 5.8% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率AUPHRHLD
| Q4 25 | 0.22× | — | ||
| Q3 25 | 1.41× | — | ||
| Q2 25 | 2.06× | — | ||
| Q1 25 | 0.06× | — | ||
| Q4 24 | 21.07× | — | ||
| Q3 24 | 1.19× | — | ||
| Q2 24 | 21.94× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AUPH
| Products | $74.2M | 96% |
| License Collaboration And Royalty Revenue | $2.9M | 4% |
RHLD
暂无分部数据
